Medicare Pilot Program Utilizing AI for Procedure Approvals
The new Medicare pilot program will necessitate prior approval for specific medical procedures where AI will determine compensation eligibility.
Updated: 6:39pm EDT August 29th, 2025
The Centers for Medicare and Medicaid Services (CMS) is introducing programs that require prior approval from insurers for certain medical procedures. The government aims to evaluate if these measures can help reduce waste, fraud, and abuse. Initial implementation is set for next year in states like Ohio, Oklahoma, Arizona, Texas, and Washington. Procedures expected to need additional steps for pre-approval include steroid injections, spinal surgeries, and skin replacements. Officials warn that billions of taxpayer dollars could be wasted annually, but the most debated aspect of the program seems to be how coverage decisions are made. The government plans to hire private AI companies to assess these cases, raising concerns about potential inappropriate denials. Experts argue that these companies might prioritize refusals since they are financially incentivized for each rejection. There’s alarm that many patients could be turned away from services they rightfully deserve. If claims are denied, patients may be stuck with costs, which means doctors encourage them to advocate for themselves—knowing their rights and doing their research is crucial.
New initiatives from the Centers for Medicare and Medicaid Services (CMS) will require prior approval from insurers for certain medical procedures. The government is investigating whether this program can help cut down on waste, fraud, and abuse, with plans to roll it out in addition to states such as New Jersey next year.
The program is targeted exclusively at traditional Medicare, which provides health insurance to millions over 65 and those with disabilities. Services facing additional pre-approval hurdles include steroid injections, spinal surgery, and alternative skin treatments—areas where unnecessary expenditures could total billions annually.
Yet, the controversial element seems to arise from how the government identifies what is excluded from coverage. By bringing in private AI firms to make these evaluations, complications could arise, as noted by experts. There’s a concern that these entities may prioritize saying “no,” as each denial directly impacts their compensation. Health professionals fear this could result in many patients being unjustly denied necessary services.
If a claim is rejected, patients might find themselves responsible for the expenses. Therefore, practitioners often advise their patients to stand up for themselves—understanding their rights, researching options, and effectively navigating through appeal processes is vital.
Experts indicate that the new prior authorization rules might make traditional Medicare less appealing, which could push more individuals toward Medicare Advantage plans. Broadly speaking, Medicare Advantage tends to involve more government costs than traditional Medicare, implying a tendency to shift funds rather than achieve savings.
Furthermore, there’s concern that the program might streamline approvals for patients who are easier to assess rather than focusing on those who genuinely need critical care. This situation has prompted some medical professionals and lawmakers to express dissatisfaction regarding the perceived lack of clarity in the government’s handling of these pilot programs.
